We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
KBR Beats on Q3 Earnings, Raises 2018 Guidance, Shares Up
Read MoreHide Full Article
KBR, Inc.’s (KBR - Free Report) shares jumped more than 8% on Oct 30 following third-quarter 2018 results, wherein earnings topped analysts’ expectation.
The company’s adjusted earnings of 46 cents per share in third-quarter 2018 beat the Zacks Consensus Estimate of 39 cents by 18% and also increased 31.4% from 35 cents a year ago.
The company’s revenues of $1,278 million lagged the consensus mark of $1,308 million but improved 23.6% year over year.
Strong organic growth from Government Services and Technology businesses, solid execution across all segments, accretive growth from Aspire and SGT, along with buoyant government contracting and hydrocarbons end markets led to the upside.
Government Services revenues rose an impressive 59.5% year over year to $928 million. The uptrend was mainly driven by 12% organic growth in the business and strong third-quarter bookings for Government Services, with a book-to-bill ratio of 1.3.
Also, Technology revenues recorded an increase of 35% year over year to $81 million. The increase was attributable to solid organic growth of 35% and strong demand for petrochemical, refining and agricultural technologies.
However, Hydrocarbons Services revenues were down 30.9% year over year to $268 million.
As of Sep 30, 2018, the company’s total backlog was $13.5 billion compared with $10.6 billion as of Dec 31, 2017. Of the total backlog, about $11.04 billion is booked under the Government Services segment (up 34.9% on a year-over-year basis) and around $1.9 billion under the Hydrocarbons Services segment. While Technology accounted for $544 million of the backlog (up 95.7% on a year-over-year basis), Non-strategic Business contributed to $3 million (down from $6 million a year ago).
Liquidity & Cash Flow
As of Sep 30, 2018, KBR’s cash and equivalents were $581 million, up from $439 million at the end of 2017.
In the quarter, cash flow provided by operating activities totaled $72 million, much higher than $28 million in the year-ago quarter.
2018 Guidance Raised
KBR increased its full-year 2018 guidance. The company currently expects adjusted earnings per share in the band of $1.45-$1.55 from $1.45-$1.50 expected earlier.
This guidance excludes legal costs associated with legacy U.S. Government contracts, as well as acquisition & integration-related expenses related to Aspire and SGT acquisitions. The estimated legacy legal fees exclude any future cost reimbursement from the U.S. Government.
The company maintained its expectation for operating cash flow, which is estimated in the range of $125-$175 million.
Jacobs Engineering surpassed the consensus estimate in the trailing four quarters, with an average surprise rate of 15.4%.
MasTec and EMCOR’s earnings per share are expected to increase 25% and 18% in 2018, respectively.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
KBR Beats on Q3 Earnings, Raises 2018 Guidance, Shares Up
KBR, Inc.’s (KBR - Free Report) shares jumped more than 8% on Oct 30 following third-quarter 2018 results, wherein earnings topped analysts’ expectation.
The company’s adjusted earnings of 46 cents per share in third-quarter 2018 beat the Zacks Consensus Estimate of 39 cents by 18% and also increased 31.4% from 35 cents a year ago.
The company’s revenues of $1,278 million lagged the consensus mark of $1,308 million but improved 23.6% year over year.
Strong organic growth from Government Services and Technology businesses, solid execution across all segments, accretive growth from Aspire and SGT, along with buoyant government contracting and hydrocarbons end markets led to the upside.
KBR, Inc. Price, Consensus and EPS Surprise
KBR, Inc. Price, Consensus and EPS Surprise | KBR, Inc. Quote
Segment Data
Government Services revenues rose an impressive 59.5% year over year to $928 million. The uptrend was mainly driven by 12% organic growth in the business and strong third-quarter bookings for Government Services, with a book-to-bill ratio of 1.3.
Also, Technology revenues recorded an increase of 35% year over year to $81 million. The increase was attributable to solid organic growth of 35% and strong demand for petrochemical, refining and agricultural technologies.
However, Hydrocarbons Services revenues were down 30.9% year over year to $268 million.
As of Sep 30, 2018, the company’s total backlog was $13.5 billion compared with $10.6 billion as of Dec 31, 2017. Of the total backlog, about $11.04 billion is booked under the Government Services segment (up 34.9% on a year-over-year basis) and around $1.9 billion under the Hydrocarbons Services segment. While Technology accounted for $544 million of the backlog (up 95.7% on a year-over-year basis), Non-strategic Business contributed to $3 million (down from $6 million a year ago).
Liquidity & Cash Flow
As of Sep 30, 2018, KBR’s cash and equivalents were $581 million, up from $439 million at the end of 2017.
In the quarter, cash flow provided by operating activities totaled $72 million, much higher than $28 million in the year-ago quarter.
2018 Guidance Raised
KBR increased its full-year 2018 guidance. The company currently expects adjusted earnings per share in the band of $1.45-$1.55 from $1.45-$1.50 expected earlier.
This guidance excludes legal costs associated with legacy U.S. Government contracts, as well as acquisition & integration-related expenses related to Aspire and SGT acquisitions. The estimated legacy legal fees exclude any future cost reimbursement from the U.S. Government.
The company maintained its expectation for operating cash flow, which is estimated in the range of $125-$175 million.
Zacks Rank & Stocks to Consider
KBR currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Zacks Construction sector include Jacobs Engineering Group Inc. , MasTec, Inc. (MTZ - Free Report) and EMCOR Group, Inc. (EME - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Jacobs Engineering surpassed the consensus estimate in the trailing four quarters, with an average surprise rate of 15.4%.
MasTec and EMCOR’s earnings per share are expected to increase 25% and 18% in 2018, respectively.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>